The challenge of eliciting opinions of gene therapy for SCD
Blood Adv
.
2023 Dec 12;7(23):7369-7370.
doi: 10.1182/bloodadvances.2023011606.
Authors
Emily M Limerick
1
,
Courtney D Fitzhugh
1
Affiliation
1
Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
PMID:
38085553
PMCID:
PMC10726235
DOI:
10.1182/bloodadvances.2023011606
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anemia, Sickle Cell* / therapy
Genetic Therapy
Humans
Risk Assessment